Ultrasensitive algorithmic detection of salmonella in chocolate
An innovative algorithmic detection method utilizing RT-qPCR and liquid enhancement cultures for rapid and sensitive Salmonella detection in chocolate. This approach minimizes the need for secondary testing by efficiently ruling out contamination in most samples.
Overview
This novel solution aims to revolutionize Salmonella detection in chocolate by employing an algorithmic approach. Utilizing rapid GN-selective liquid enhancement cultures combined with 'unextracted' RT-qPCR, this method targets both eubacterial 16S rRNA and specific Salmonella genes. This dual-targeting strategy efficiently rules out contamination in most chocolate samples, significantly reducing the need for time-consuming secondary testing.
Technical specifications
Key features:
- Utilizes RT-qPCR for rapid detection of Salmonella and general eubacterial presence.
- GN-selective liquid enhancement cultures enhance the detection sensitivity.
- Multistep algorithm increases specificity and reduces unnecessary secondary testing.
- Complies with food microbiology guidelines (ISO 16140-2) and leverages clinical diagnostic principles.
- Includes statistical determination of limit of detection (LOD) and validation through diverse bacterial strains.
Technology readiness level
Currently at Technology Readiness Level 3, this solution has undergone early-stage validation, including limit-of-blank analyses and initial testing in controlled conditions. Further validation will include prospective blinded studies comparing with traditional culture methods, aiming to refine diagnostic sensitivity and specificity over the next year.
About Vanderbilt University Medical Center
Vanderbilt University Medical Center is a large, independent academic medical center and health system in Nashville, uniting patient care, research, and training at scale. Co-located hospitals and research facilities give partners access to core labs, biobanking, advanced imaging, and secure, de‑identified EHR data resources. A centralized trials office, experienced contracting, and proximity to Nashville’s healthcare management cluster streamline multi-site studies and real‑world evidence work. Research is backed by competitive federal funding, led by NIH and complemented by DoD and CDC. A dedicated technology transfer office supports IP, licensing, and startup formation to accelerate clinical translation.
delivered to your inbox.